Ryan Allway April 22nd, 2021 App, Exclusive, Psychedelics, Top Story The psychedelics industry has experienced a renaissance over the past few years as researchers have opened a pandora’s box of potential. From major depression to generalized anxiety to post-traumatic stress disorder, emerging research suggests that psychedelic substances could have... Read more
Ryan Allway April 9th, 2021 App, Exclusive, Psychedelics, Top News The psychedelics sector is quickly evolving into a multi-billion-dollar industry with a growing number of publicly traded companies. As with any new industry, there are many companies backed by little more than financiers looking to make a quick dollar... Read more
Ryan Allway February 26th, 2021 Exclusive, German “Patent angemeldet” ist ein Ausdruck, mit dem Sie wahrscheinlich vertraut sind. Sie haben gesehen, wie es auf der Seite eines Dinges im Einkaufszentrum gestempelt wurde, oder Sie haben es in der Fernsehsendung gehört, die Sie gerade anschauen, und Sie denken sich: „Wow,... Read more
Ryan Allway January 22nd, 2021 Psychedelics, Top News VANCOUVER, BC / ACCESSWIRE / January 22, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the “Company” or “Havn Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that it will... Read more
Ryan Allway November 4th, 2020 App, Exclusive, Psychedelics, Top Story Most pharmaceutical and biotech investors are familiar with long commercialization timelines, but there are a few ways to shortcut the process. For example, the Food and Drug Administration provides Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review designations... Read more
Ryan Allway October 29th, 2020 German, Psychedelics Der nordamerikanische Markt für psychedelische Medikamente wird vorraussichtlich bis 2027 6.85 Milliarden USD erreichen, nach Daten der Data Bride Market Research, das entspricht einer jährlichen Wachstumsrate von 16.3%. Nach der Genehmigung von Johnson & Johnsons (NYSE: jnj) SPRAVATO Nasenspray für behandlusngsresistente Depressionen... Read more
Ryan Allway October 2nd, 2020 App, Exclusive, News, Psychedelics, Top News The psychedelics industry is poised to become a nearly $7 billion market by 2027, according to Data Bridge Market Research, driven by the potential to revolutionize the treatment of mental health disorders. While investors have many options in... Read more